Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu–Natal, South Africa KI Barnes, DN Durrheim, F Little, A Jackson, U Mehta, E Allen, SS Dlamini, ... PLoS medicine 2 (11), e330, 2005 | 372 | 2005 |
Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study U Mehta, DN Durrheim, M Blockman, T Kredo, R Gounden, KI Barnes British journal of clinical pharmacology 65 (3), 396-406, 2008 | 173 | 2008 |
Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross‐sectional survey JP Mouton, U Mehta, AG Parrish, DPK Wilson, A Stewart, CW Njuguna, ... British journal of clinical pharmacology 80 (4), 818-826, 2015 | 120 | 2015 |
Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa JP Mouton, C Njuguna, N Kramer, A Stewart, U Mehta, M Blockman, ... Medicine 95 (19), e3437, 2016 | 109 | 2016 |
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: a randomised trial (DolPHIN-1 study) C Waitt, C Orrell, S Walimbwa, Y Singh, K Kintu, B Simmons, ... PLoS medicine 16 (9), e1002895, 2019 | 106 | 2019 |
Developing a national system for dealing with adverse events following immunization U Mehta, JB Milstien, P Duclos, PI Folb Bulletin of the World Health Organization 78 (2), 170-177, 2000 | 96 | 2000 |
Is it safe to switch between efavirenz and nevirapine in the event of toxicity? U Mehta, G Maartens The Lancet Infectious Diseases 7 (11), 733-738, 2007 | 62 | 2007 |
Vaccine safety basics: learning manual M Mort, A Baleta, F Destefano, JG Nsubuga, C Vellozzi, U Mehta, R Pless, ... Vaccine safety basics: learning manual, 2013 | 58 | 2013 |
Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety U Mehta, DN Durrheim, L Blumberg, S Donohue, F Hansford, A Mabuza, ... Tropical Medicine & International Health 12 (5), 617-628, 2007 | 51 | 2007 |
Clinical practice Strengthening pharmacovigilance in South Africa U Mehta, M Blockman, G Maartens South African Medical Journal 104 (2), 104-106, 2014 | 43 | 2014 |
Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the … JP Mouton, U Mehta, DP Rossiter, G Maartens, K Cohen PLoS one 12 (2), e0172830, 2017 | 42 | 2017 |
Spontaneous adverse drug reaction reporting in rural districts of Mozambique E Sevene, A Mariano, U Mehta, M Machai, A Dodoo, D Vilardell, S Patel, ... Drug safety 31, 867-876, 2008 | 42 | 2008 |
Pharmacovigilance: a public health priority for South Africa U Mehta, E Kalk, A Boulle, P Nkambule, J Gouws, H Rees, K Cohen South African health review 2017, 125, 2017 | 40 | 2017 |
Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings U Mehta, C Clerk, E Allen, M Yore, E Sevene, J Singlovic, M Petzold, ... BMC pregnancy and childbirth 12, 1-13, 2012 | 40 | 2012 |
Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021) E Farley, U Mehta, ML Srour, A Lenglet PLoS neglected tropical diseases 15 (12), e0009844, 2021 | 39 | 2021 |
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study TR Malaba, I Nakatudde, K Kintu, A Colbers, T Chen, H Reynolds, L Read, ... The Lancet HIV 9 (8), e534-e543, 2022 | 37 | 2022 |
Pharmacovigilance: the devastating consequences of not thinking about adverse drug reactions: The burden of adverse drug reactions (ADRs) on patient care has been found to be … UC Mehta Continuing medical education 29 (6), 2011 | 35 | 2011 |
The prevalence of noma in northwest Nigeria E Farley, MJ Oyemakinde, J Schuurmans, C Ariti, F Saleh, G Uzoigwe, ... BMJ global health 5 (4), e002141, 2020 | 32 | 2020 |
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis M Saito, R McGready, H Tinto, T Rouamba, D Mosha, S Rulisa, S Kariuki, ... The Lancet 401 (10371), 118-130, 2023 | 30 | 2023 |
Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa U Mehta, D Durrheim, A Mabuza, L Blumberg, E Allen, KI Barnes Drug safety 30, 899-910, 2007 | 30 | 2007 |